BIO-key closes $3.75M public offering; net $3.3M to repay debt and for working capital

BIO KEY INTERNATIONAL INC

Gross proceeds $3.75M from sale of 21.43M units at $0.175/unit; each unit comprises one share (or pre-funded warrant) and one 5-year warrant exercisable at $0.175.
Net proceeds approximately $3.3M after deducting placement agent fees and offering expenses.
Company intends net proceeds to repay up to $2.2M of outstanding debt and for general corporate and working capital.
Offering closed October 31, 2023; Maxim Group LLC acted as sole placement agent with a 7% cash fee.

item 1.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BIO KEY INTERNATIONAL INC entered into Purchase Agreement with certain investors (effective 2023-10-30).

Action: entry
Agreement: equity purchase
Counterparty: certain investors
Effective: 2023-10-30

Exact text from the filing

On October 30, 2023, BIO-key International, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with certain investors in connection with a public offering of the Company’s securities (the “ Offering ”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BIO KEY INTERNATIONAL INC entered into Placement Agency Agreement with Maxim Group LLC (effective 2023-10-30).

Action: entry
Agreement: underwriting
Counterparty: Maxim Group LLC
Effective: 2023-10-30

Exact text from the filing

On October 30, 2023, the Company entered into a placement agency agreement (the “ Placement Agency Agreement ”) with Maxim Group LLC to serve as its exclusive placement agent in connection with the Offering.

View on SEC.gov

Browse all material agreements →

BIO KEY INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001437749-23-029920

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.